{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:02:32Z","timestamp":1780038152528,"version":"3.53.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Microinflammation is widespread in Maintenance hemodialysis (MHD) patients. The continuous interaction of microinflammation and malnutrition is an independent risk factor for the clinical prognosis of MHD patients. Nutritional vitamin D deficiency is closely related to chronic kidney disease inflammation, but whether correcting this deficiency can improve microinflammation in the MHD population remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Studies published up to March 1, 2025 were included. Risk of bias was assessed using the Cochrane tool. RevMan 5.4 and Stata 17 were used for analyses, with heterogeneity assessed and random-effects models applied. Key outcomes included CRP, serum albumin, TNF-\u03b1, IL-1\u03b2, immunoreactive Parathyroid Hormone (iPTH), adverse events, hypercalcemia, and hyperphosphatemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 617 patients in eight randomized controlled trials were included. The experimental group interventions were nutritional vitamin D, while those of the control group were placebo. The meta-analysis showed that the decrease in CRP in the nutritional vitamin D intervention group was significantly higher than that in the control group [MD \u22123.15, 95% confidence interval (CI; \u22124.46, \u22121.84),\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05]. Subgroup analysis demonstrated that nutritional vitamin D supplementation not only reduced CRP in MHD patients with baseline vitamin D deficiency, but also in those with normal vitamin D baseline levels [MD \u22122.64, 95% CI (\u22124.47, \u22120.81),\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05; MD \u22123.97, 95% CI (\u22125.78, \u22122.17),\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05]. The increase in serum albumin in the vitamin D group was more significant than in the control group [MD 0.55, 95% CI (0.10, 1.01),\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05]. iPTH decreased more significantly in the vitamin D group than in the control group [SMD \u22120.56, 95% CI (\u22121.07, \u22120.05),\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05]. In terms of safety, the overall incidence of adverse reactions in the nutritional vitamin D group was similar to that in the control group (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.09). Moreover, no significant differences were found in the incidence of hypercalcemia and hyperphosphatemia between the two groups (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.15,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.32).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Nutritional vitamin D supplementation may improve microinflammation and nutritional status in MHD patients, with potential benefits for bone metabolism and no apparent increase in the risk of hypercalcemia or hyperphosphatemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1767616","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:11:08Z","timestamp":1780035068000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of nutritional vitamin D on microinflammation and nutritional status in maintenance hemodialysis patients: a meta-analysis of randomized controlled trials"],"prefix":"10.3389","volume":"13","author":[{"given":"Chen","family":"Li","sequence":"first","affiliation":[{"name":"Department of Nephrology, The First Hospital of Jilin University, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Hospital of Jilin University, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Hospital of Jilin University, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Hospital of Jilin University, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3969\/j.issn.1671-4091.2024.05.001","article-title":"Research report on the development of China's hemodialysis","volume":"23","author":"Chinese Hospital Association Blood Purification Center","year":"2024","journal-title":"Chin J Blood Purif"},{"key":"B2","unstructured":"Bethesda, MD\n          National Institute of Diabetes and Digestive and Kidney Diseases\n          2024 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States\n          \n          2024"},{"key":"B3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000542418","article-title":"Severe coronary artery calcifications in chronic kidney disease patients, coupled with inflammation and bone mineral disease derangement, promote major adverse cardiovascular events through vascular remodeling","volume":"50","author":"Morena-Carrere","year":"2025","journal-title":"Kidney Blood Press Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1046\/j.1523-1755.2002.00637.x","article-title":"Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage?","volume":"62","author":"Stenvinkel","year":"2002","journal-title":"Kidney Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/15548627.2019.1569298","article-title":"Vitamin D improves sunburns by increasing autophagy in M2 macrophages","volume":"15","author":"Das","year":"2019","journal-title":"Autophagy"},{"key":"B6","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/ije\/dyac087","article-title":"Vitamin D deficiency and C-reactive protein: a bidirectional Mendelian randomization study","volume":"52","author":"Zhou","year":"2023","journal-title":"Int J Epidemiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000202632","article-title":"25-hydroxyvitamin D deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease","volume":"30","author":"Kendrick","year":"2009","journal-title":"Am J Nephrol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/jcb.10453","article-title":"Modulation of TNF-alpha expression in bone marrow macrophages: involvement of vitamin D response element","volume":"88","author":"Hakim","year":"2003","journal-title":"J Cell Biochem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/ndt\/gfu311","article-title":"The induction of C\/EBPB contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease","volume":"30","author":"Arcidiacono","year":"2015","journal-title":"Nephrol Dial Transplant."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.3390\/nu14112285","article-title":"Oral cholecalciferol supplementation in Sahara black people with chronic kidney disease modulates cytokine storm, oxidative stress damage and athero-thromboembolic risk","volume":"14","author":"Zoubiri","year":"2022","journal-title":"Nutrients"},{"key":"B11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1542-4758.2007.00186.x","article-title":"Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis","volume":"11","author":"Del Valle","year":"2007","journal-title":"Hemodial Int."},{"key":"B12","first-page":"827","article-title":"Vitamin D and micro-inflammatory state in hemodialysis patients: a mini review and meta-analysis","volume":"30","author":"Huang","year":"2016","journal-title":"J Biol Regul Homeost Agents"},{"key":"B13","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.numecd.2020.09.014","article-title":"The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: a randomized placebo controlled study","volume":"31","author":"Alshahawey","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"700","DOI":"10.53350\/pjmhs22165700","article-title":"Outcome of cholecalciferol supplementation on bone mineral metabolism in end stage renal disease patients in comparison with placebo: randomized control trial","volume":"16","author":"Ayub","year":"2022","journal-title":"Pak J Med Health Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1821","DOI":"10.6061\/clinics\/2021\/e1821","article-title":"In vitro anti-inflammatory effects of vitamin D supplementation may be blurred in hemodialysis patients","volume":"76","author":"Greg\u00f3rio","year":"2021","journal-title":"Clinics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1093\/ndt\/gfs138","article-title":"Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D","volume":"27","author":"Marckmann","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1681\/ASN.2015040468","article-title":"Ergocalciferol supplementation in hemodialysis patients with vitamin D deficiency: a randomized clinical trial","volume":"27","author":"Miskulin","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000354717","article-title":"Influence of cholecalciferol supplementation in hemodialysis patients on monocyte subsets: a randomized, double-blind, placebo-controlled clinical trial","volume":"123","author":"Seibert","year":"2013","journal-title":"Nephron Clin Pract."},{"key":"B23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.14715\/cmb\/2022.68.5.2","article-title":"The effectiveness of vitamin D supplementation on oxidative and inflammatory markers in patients suffering from end-stage renal disease: a randomized controlled trial","volume":"68","author":"Sharif","year":"2022","journal-title":"Cell Mol Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1055\/s-0043-119221","article-title":"Clinical trial on the effects of vitamin D supplementation on metabolic profiles in diabetic hemodialysis","volume":"50","author":"Tamadon","year":"2018","journal-title":"Horm Metab Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000014457","article-title":"The microinflammatory state of uremia","volume":"18","author":"Sch\u00f6mig","year":"2000","journal-title":"Blood Purif."},{"key":"B26","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney","year":"2024","journal-title":"Kidney Int"},{"key":"B27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1755-6686.2011.00201.x","article-title":"Malnutrition-inflammation-atherosclerosis syndrome in patients with end-stage renal disease","volume":"37","author":"Zyga","year":"2011","journal-title":"J Ren Care"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","author":"Wolf","year":"2007","journal-title":"Kidney Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2015.11.029","article-title":"Pleiotropic effects of vitamin D in chronic kidney disease","volume":"453","author":"Liu","year":"2016","journal-title":"Clin Chim Acta"},{"key":"B30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0272-6386(00)70200-9","article-title":"C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients","volume":"35","author":"Yeun","year":"2000","journal-title":"Am J Kidney Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.3390\/nu15245036","article-title":"Clinical significance of nutritional status, inflammation, and body composition in elderly hemodialysis patients: a case-control study","volume":"15","author":"Ruperto","year":"2023","journal-title":"Nutrients"},{"key":"B32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s43094-024-00696-0","article-title":"Cholecalciferol effect on oxidative stress and novel predictors of inflammation in hemodialysis patients: a prospective randomized trial","volume":"10","author":"Alshahawey","year":"2024","journal-title":"Future J Pharm Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/hdi.12316","article-title":"Association of low vitamin D levels with metabolic syndrome in hemodialysis patients","volume":"20","author":"Ahmadi","year":"2016","journal-title":"Hemodial Int."},{"key":"B34","doi-asserted-by":"publisher","first-page":"gfad063c_2918","DOI":"10.1093\/ndt\/gfad063c_2918","article-title":"Serum 25(OH)-vitamin D and 1,25(OH)2 vitamin D in hemodialysis patients: factors affecting their concentrations and their effect on survival","volume":"38","author":"Ishimura","year":"2023","journal-title":"Nephrol Dial Transplant"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1767616\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:11:12Z","timestamp":1780035072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1767616\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":34,"alternative-id":["10.3389\/fnut.2026.1767616"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1767616","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1767616"}}